B-vitamins and bone health
This article was originally published in The Tan Sheet
Executive SummaryB-vitamin supplementation was found to produce no consistent effects on bone turnover or body mass index, however, the vitamin may have different effects in patients with hyperhomocysteinemia, Markus Herrmann et al., University of Sydney, conclude in a study published in the Nov. 18 journal Clinical Chemistry and Laboratory Medicine. The one-year, double-blinded, placebo-controlled trial analyzed the effect of homocysteine-lowering B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients. The study included 47 subjects ages 55 to 82 who were treated with either a combination of 2.5 mg folate, 0.5 mg vitamin B12 and 25 mg vitamin B6, or placebo; bone mineral density at lumbar spine and hip was measured at base line and after one year. Vitamin B was the focus of a recent Norwegian study that evaluated the effects of vitamin B on cardiovascular events and concluded it is not justified as secondary prevention in reducing risk of death or major cardio events (1"The Tan Sheet" Sept. 10, 2007, In Brief)...
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.